Codexis to Participate in Jefferies Healthcare Conference
May 24 2023 - 3:05PM
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,
today announced the Company will attend the Jefferies Healthcare
Conference, being held June 7-9, 2023, in New York, New York.
Management will participate in a fireside chat on Wednesday,
June 7, 2023, at 1:00 pm ET. A live webcast of the event will be
available in the Investor Relations section of the Company’s
website, http://ir.codexis.com. A replay will be archived for 90
days following the event.
About Codexis
Codexis is a leading enzyme engineering company leveraging its
proprietary CodeEvolver® technology platform to discover, develop
and enhance novel, high-performance enzymes and other classes of
proteins. Codexis enzymes solve for real-world challenges
associated with small molecule pharmaceuticals manufacturing,
nucleic acid synthesis and genomic sequencing, and – as
biotherapeutic candidates – they have the potential to treat
challenging diseases. Codexis’ unique enzymes can drive
improvements such as higher yields, reduced energy usage and waste
generation, improved efficiency in manufacturing, greater
sensitivity in genomic and diagnostic applications and potentially
more efficacious therapeutics. For more information,
visit www.codexis.com.
For More Information
Investor ContactCarrie McKim(336) 608-9706ir@codexis.com
Media ContactLauren Musto(781) 572-1147media@codexis.com
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jul 2023 to Jul 2024